Affordable Access

Publisher Website

Functional neuroimaging in schizophrenia: diagnosis and drug discovery

Authors
Journal
Trends in Pharmacological Sciences
0165-6147
Publisher
Elsevier
Publication Date
Volume
29
Issue
2
Identifiers
DOI: 10.1016/j.tips.2007.11.005
Disciplines
  • Biology
  • Medicine
  • Physics

Abstract

Functional neuroimaging provides a direct way of investigating the pathophysiology of schizophrenia in vivo. The function of neurotransmitters implicated in schizophrenia, such as dopamine and glutamate, can be assessed using molecular imaging techniques such as positron emission tomography (PET), single-photon emission tomography (SPET) and magnetic resonance spectroscopy (MRS). Regional brain activity, particularly that associated with the cognitive processes and symptoms associated with the disorder, can be studied using functional magnetic resonance imaging (fMRI). Here, we focus on the potential for the use of these techniques in the diagnosis of schizophrenia and in the development of new drugs for its treatment.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

[Role of neuroimaging biomarker in drug discovery...

on Nihon yakurigaku zasshi. Folia... September 2012

Functional brain connectivity phenotypes for schiz...

on Journal of Psychopharmacology February 2015

Review of longitudinal functional neuroimaging stu...

on Schizophrenia research Oct 01, 2005

Review of longitudinal functional neuroimaging stu...

on Schizophrenia Research Jan 01, 2005
More articles like this..